Precision System Science, Co., Ltd. (“PSS”) hereby announces that its Board of Directors has resolved at the meeting held on May 15, 2017 to conclude a capital and business alliance with Hitachi High-Technologies Corporation (“Hitachi High-Tech”) (this alliance hereinafter referred to as the “Capital and Business Alliance”) and to issue new shares through a third-party […]
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has appointed Dr. Madhuri Hegde as vice president and chief scientific officer for its newly created Laboratory Services group within its Diagnostics business. PerkinElmer’s Laboratory Services group brings together the Company’s global diagnostic lab resources to provide comprehensive genetic screening and diagnostic […]
Streck, Inc. and Genomax Technologies, a life sciences products distributor in Singapore and Malaysia, have signed a distribution agreement for Streck’s cell stabilization and molecular products. Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; Cyto-Chex® BCT, a blood collection tube for the preservation […]
AMSBIO has introduced a new range of ready-to-use Reporter Lentivirus for assessing cell signaling activities in virtually any mammalian cell type. These pre-made products use a unique combination of transcription factor reporter technology coupled with lentiviral delivery to provide a simple, highly sensitive method capable of operating over a large dynamic range. By measuring the […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Elisha W. Finney, former executive vice president and chief financial officer at Varian Medical Systems (NYSE: VAR), to its Board of Directors and Audit Committee. Ms. Finney brings more than 25 years of financial and life […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced it will commence a global search for a new Chief Executive Officer in conjunction with the planned retirement of John A. Kraeutler in accordance with the terms of his employment agreement. Mr. Kraeutler plans to continue to serve in the capacity of CEO until his successor is found. Going forward he […]
New investor Dell Technologies Capital leads round; all existing investors participate SAN DIEGO – Edico Genome announced today it has raised $22 million in a Series B financing to expand market adoption and product development of its DRAGEN™ platform, an end-to-end solution for analysis of next-generation sequencing data. New investor Dell Technologies Capital, the venture arm […]
Leading Big Data company developing platform with clinical and genomic data from 5 million subjects, to transform drug development and bring clinical benefits to patients. BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction […]
Licensing agreement will support Oxford Genetics growing bio-therapeutic discovery, development and manufacturing service business. Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery and development, today announces it has signed a non-exclusive licensing agreement with ERS Genomics to access its foundational intellectual property related to CRISPR/Cas9 gene editing technology. […]
Boulder, CO – Muse bio, a privately-held company leading the development of next-generation genome engineering capabilities, today announced Dr. John Stuelpnagel, co-founder, first CEO and former COO of Illumina and a well-known genomics industry entrepreneur, will become Chairman of Muse bio’s Board of Directors. In addition to Illumina, Dr. Stuelpnagel has co-founded and held senior […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
